PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION

The summary for the PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION
	CFDA Number:	93.394
	CFDA Description:	Cancer Detection and Diagnosis Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Education
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-04-102
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	May 10, 2004
	Creation Date:	May 26, 2006
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jun 02, 2006
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$200,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: County governments Independent school districts State governments Special district governments Public housing authorities/Indian housing authorities City or township governments Private institutions of higher education Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Information not provided
Grant Description: The Cancer Diagnosis Program of the National Cancer Institute invites applications for research projects to evaluate the utility and pilot the application of new strategies for determining prognosis or predicting response to therapy. This will provide tools to improve clinical decision-making in the care of cancer patients. This PA provides support for a first phase (R21) for technical development and a second phase (R33) for application and evaluation of clinical utility. The first phase should produce data to demonstrate the technical feasibility of the study design proposed for the second phase, including the analytic performance of the assay or test system on samples comparable to those that will be used in the second phase. The second phase should be designed to test whether application of the strategy will provide clinical benefit to a defined set of cancer patients.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-04-102.html http://grants.nih.gov/grants/guide/pa-files/PA-04-102.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants: • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21); • Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01); • Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01); • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technolog...; • Opportunity RFA-AI-10-030; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS; • Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis; • IN VIVO CELLULAR AND MOLECULAR IMAGING CENTERS (ICMICs)